Acoltremon Enantiomer | CAS 3038740-43-8 - Request Quote
Acoltremon Enantiomer
| SZ CAT No: | SZ-A232002 |
| CAS No | 3038740-43-8 |
| Mol.F. | C18H27NO2 |
| Mol.Wt. | 289.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Acoltremon Enantiomer is chemically (1S,2R,5S)-2-isopropyl-N-(4-methoxyphenyl)-5-methylcyclohexane-1-carboxamide. Acoltremon Enantiomer is supplied with detailed characterization data compliant with regulatory guideline. Acoltremon Enantiomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Acoltremon.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3038740-43-8
Purchase 3038740-43-8
Order 3038740-43-8
Enquire 3038740-43-8
price of 3038740-43-8
3038740-43-8 Supplier
3038740-43-8 Manufacturer
3038740-43-8 Exporter
buy high quality Acoltremon Enantiomer
Purchase Acoltremon Enantiomer
Acoltremon Enantiomer suppliers
Acoltremon Enantiomer manufacturers
Acoltremon Enantiomer price
Order Acoltremon Enantiomer
Enquire Acoltremon Enantiomer
Acoltremon Enantiomer cost
Acoltremon Enantiomer Supplier
Acoltremon Enantiomer Distributor
Acoltremon Enantiomer for Method Validation
Acoltremon Reference Standard
Acoltremon Enantiomer for ANDA Filing
Acoltremon Enantiomer for Forced Degradation Studies
Acoltremon Enantiomer Identification Standards
Acoltremon Enantiomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.